aggressive scapular chondroblastoma with secondary metastasis
TRANSCRIPT
EUROPEAN JOURNAL OF MEDICAL RESEARCH 1
AbstractChondroblastoma is a benign bone tumor, accountingfor approximately one percent of all benign bone tu-mors. It mostly occurs in typical locations such as longbones. Malignant transformation including metastasishas been described in only a few cases. Therefore, wereport a unique case of chondroblastoma with tumormanifestation in the 7th decade of life, location of thetumor in the scapula and occurrence of metastasis inthe soft tissue of the mandible branch. Due to aggra-vation of the clinical course, a scapula en bloc resec-tion was performed. The differential diagnosis is dis-cussed and the current literature concerning malignanttransformation of chondroblastoma is reviewed.
Key words: Chondroblastoma, malignant transforma-tion, en bloc resection therapy, metastasis
INTRODUCTION
Chondroblastoma is a benign bone tissue tumor,which was first reported by Codman in 1931 in termsof an “epiphyseal chondromatous giant cell tumor”.This rare tumor entity accounts for approximately onepercent of all benign bone tumors, most frequentlyfound in young male patients with a peak incidence inthe second decade of life. Although chromosomal ab-normalities have been reported, no specific alterationhas been detected so far. Typical tumor locations arethe long bones, especially femur, tibia and proximalhumerus. Common clinical symptoms are pain and adecreasing range of motion of adjacent joints. In con-ventional radiographs, signs of asymmetric epiphysealdestruction, often including bone expansion and scle-rotic margins, can be seen. In histological staining, thepredominant cells are most similar to epiphyseal chon-drocytes, expressing distinct morphological featuresfor differentiation. Although most authors assume thetumor being of essentially benign character, 11 casesof malignant transformation including metastasis havebeen reported in the literature (Table 1). In this con-text, the present case appears unique due to 1) thescapular location of the tumor, 2) the occurrence ofmetastasis in the soft tissue of the mandible branch,and 3) a course of disease lasting more than 40 yearswith tumor manifestation in the 7th decade.
CASE REPORT
A 68-year-old man in good physical condition present-ed with limitation of left shoulder mobility. Physicalexamination revealed a tumor along the dorsolateraledge of the left scapula with atrophy of the left shoul-der girdle musculature compared to the right side. Thepatient felt pain in palpation of the lesion and at thelateral shoulder edge. Active adduction/abduction ac-counted for only 20–0–30, the passive one for20–0–50 degrees with a restriction of rotational move-ment. The neurovascular status was inconspicuous ex-cept a significant strength loss of the left versus theright hand. No lymphadenopathy, fever, chills, orweight changes were present; the laboratory findingswere within normal ranges.
Computed tomography (CT) showed a huge tumormainly of soft tissue appearance with significant ossifi-cation and partial destruction of the left scapula. In a99mTc bone scintigraphy, a significant enhancementof activity in the tumor surrounding in terms of theproximal left scapula and a large expansion into thesuprascapular tissue was detected. In magnetic reso-nance imaging (MRI), a lesion of 11 x 7 x 9 cm in size,partly lobulated and nodular with expansion startingfrom the spina scapulae, was visualized with distinctareas in T1- and T2-weighted images before and afterapplying contrast medium indicating necrotic areas.The tumor itself showed a distinct contrast enhance-ment with infiltration of the rotator cuff and the originof the subscapularis muscle. The branches of brachialplexus as well as the subclavian artery appeared with-out infiltration. The histological examination of abiopsy established the diagnosis of Langerhans' cellhistiocytosis. After 15 cycles of fractional radiation upto a maximum of 30 Gy, restaging showed a neitherclinical nor radiological regression of the tumor 6months after primary diagnosis. A second biopsy didnot confirm the diagnosis of a Langerhans' cell histio-cytosis, but diagnosed a benign chondroblastoma.Since the patient refused to undergo surgery, he wasreassigned every 6 months for control examinations.Three years after the patient's first presentation, a sig-nificant clinical aggravation of the tumor was ob-served (Fig. 1). For the mobility of the shoulder, activeadduction/abduction now accounted for 20–0–10, the
Eur J Med Res (2006) 11: 1-7 © I. Holzapfel Publishers 2006
AGGRESSIVE SCAPULAR CHONDROBLASTOMA WITH SECONDARY
METASTASIS – A CASE REPORT AND REVIEW OF LITERATURE
C. Kirchhoff1, S. Buhmann2, T. Mussack3, J. Müller-Höcker4, M. Schmitt-Sody1, V. Jansson1, H.-R. Dürr1
1Orthopädische Klinik und Poliklinik, 2Institut für Klinische Radiologie, 3Chirurgische Klinik und Poliklinik-Innenstadt, 4Institut für Pathologie,
Klinikum der Ludwig-Maximilians Universität München, Munich, Germany
EUROPEAN JOURNAL OF MEDICAL RESEARCH2
Tab
le 1
.Tab
le o
f all
patie
nts
with
his
tolo
gica
lly p
rove
n m
etas
tase
s of
a c
hond
robl
asto
ma,
rep
orte
d in
the
liter
atur
e si
nce
1931
Au
thor
(R
ef.)
Ag
e,
Site
of
Pri
mar
yC
ours
e an
d T
reat
men
tIn
terv
al t
o F
ollo
w U
pSe
xm
etas
tase
s
Dah
lin D
.C. [
5]-
Pelv
is1)
Rep
eate
d co
urse
s of
rad
iatio
n th
erap
y; 2
) Mul
tiple
pul
mon
ary
met
asta
ses
58 m
onth
sD
eath
due
to p
ulm
onar
y m
etas
tase
sG
awlik
Z. [
8]6
fem
Prox
. Hum
erus
1) I
nter
scap
ulot
hora
cic
ampu
tatio
n; 2
) Med
iast
inal
and
pul
mon
ary
met
asta
ses;
3
mon
ths
Dea
th d
ue to
wid
espr
ead
pulm
onar
y3)
Tho
raco
tom
ym
etas
tase
sG
reen
P. [
9]13
fem
Prox
. fem
ur1)
Loc
al r
ecur
renc
e an
d m
ultip
le p
ulm
onar
y m
etas
tase
s; 2
) Tho
raco
tom
y20
mon
ths
Stab
le p
ulm
onar
y le
sion
sH
uvos
A.G
. [10
]16
fem
Dis
t. fe
mur
1) C
uret
tage
; 2) L
ocal
rec
urre
nce
with
pul
mon
ary
nodu
le11
mon
ths
No
furt
her
met
asta
ses
3) C
uret
tage
and
cry
osur
gery
; 4) M
ultip
le b
ilate
ral p
ulm
onar
y no
dule
s5)
Tho
raco
tom
y Ja
mbh
ekar
NA
. [13
]27
fem
Tal
us, p
ulm
onar
y 1)
Exc
isio
n of
talu
s; 2
) 2 Y
rs. L
ater
thor
acot
omy
3 yr
s.St
able
pul
mon
ary
lesi
ons
met
asta
ses
3) R
ecur
renc
e of
pul
mon
ary
nodu
leJo
shi D
.D. [
15]
17 fe
mFi
bula
1) R
esec
tion
of p
rimar
y tib
ial C
B, t
hora
cosc
opic
res
ectio
n of
pul
mon
ary
nodu
les
Aft
er th
ree
year
s st
ill in
goo
dPu
lmon
ary
2)Lo
cal r
ecur
renc
e an
d pu
lmon
ary
met
asta
sis
-co
nditi
on w
ith s
tabl
e pu
lmon
ary
met
asta
ses
3)R
esec
tion
of b
one
and
soft
tiss
ue m
etas
tase
sm
etas
tase
sK
ahn
L.B
. [16
]13
mal
ePe
lvis
1) C
uret
tage
; 2) L
ocal
rec
urre
nce
and
pulm
onar
y m
etas
tasi
s9
yrs.
Dea
th d
ue to
met
asta
sis
15 y
rs
3) T
hree
tim
es c
uret
tage
and
res
ectio
n of
the
prim
ary
afte
r 1s
tcu
rett
age
Kha
lili K
. [17
]43
mal
eR
ib1)
Res
ectio
n; 2
) Diff
use
soft
tiss
ue m
etas
tase
s (s
calp
, nec
k, e
lbow
, but
tock
)5
yrs.
No
loca
l nor
pul
mon
ary
met
asta
ses
Kun
ze E
. [18
]33
mal
ePe
lvis
1) H
emip
elve
ctom
y; 2
) Pul
mon
ary
met
asta
ses
12 y
rs.
Stab
le p
ulm
onar
y le
sion
sK
yria
kos
M. [
19]
9 m
ale
Prox
. tib
ia1)
Cur
etta
ge a
nd b
one
pack
ing.
Tho
raco
tom
ic r
esec
tion
of tw
o no
dule
sFi
ve y
ears
aft
er 1
stsu
rger
y de
ath
due
2 pu
lmon
ary
2) L
ocal
rec
urre
nce,
innu
mer
able
pul
mon
ary
nodu
les,
fem
oral
met
asta
sis
-to
met
asta
ses
nodu
les
3) S
yste
mic
che
mot
hera
py, f
ollo
wed
by
cure
ttag
e of
the
tibia
l rec
urre
nce
Ram
appa
A. [
22]
29 m
ale
Pelv
is1)
Res
ectio
n; 2
) Mul
tiple
ske
leta
l, pu
lmon
ary
met
asta
ses
-D
eath
due
to m
etas
tase
s3)
Wid
e re
sevc
tion
49 fe
mR
ib1)
Res
ectio
n; 2
) Mul
tiple
ske
leta
l, so
ft ti
ssue
met
asta
ses
No
furt
her
recu
rren
ce o
bser
ved
3) R
esec
tion
and
radi
ofre
quen
cy a
blat
ion
Rid
dell
R.J.
[23]
14 fe
mPr
ox. t
ibia
1) C
uret
tage
and
inse
rtio
n of
bon
e gr
aft;
2) L
ocal
rec
urre
nce
with
pul
mon
ary
34 m
onth
sSt
able
pul
mon
ary
met
asta
ses
met
asta
ses;
3) M
id-t
high
am
puta
tion
and
thor
acot
omy
Scha
jow
icz
F. [2
4]32
fem
Dis
t. m
etat
arsu
sLo
cal r
ecur
renc
e an
d m
etas
tasi
s in
the
glut
eal a
nd n
eck
regi
on5
mon
ths
Dea
th 6
yea
rs a
fter
1st
diag
nosi
sSi
rsat
M.V
. [25
]15
mal
eR
t. Pr
ox. t
ibia
1) C
uret
tage
and
gra
ft; 2
) Wel
l for
2 y
rs.
unkn
own
Die
d du
e to
live
r m
etas
tase
s 9y
rs.
3) L
ocal
rec
urre
nces
; 4) A
mpu
tatio
naf
ter
1st d
iagn
osis
Swee
tnam
R. [
26]
19 m
ale
Prox
. fib
ula
1) P
ulm
onar
y m
etas
tase
s; 2
) Lob
ecto
my
-N
o fu
rthe
r m
etas
tase
sV
an H
orn
J.R. [
29]
Dis
t. fe
mur
1) C
uret
tage
and
bon
e gr
aftin
g; 2
) Pat
holo
gic
frac
ture
due
to lo
cal r
ecur
renc
e2
yrs.
No
furt
her
met
asta
ses
3) R
esec
tion
and
arth
rode
sis;
4) 1
0 yr
s. L
ater
pul
mon
ary
met
asta
sis
5) T
hora
coto
my
Wel
lman
n K
. [30
] *29
mal
eSc
apul
a1)
For
equa
rter
am
puta
tion;
2) p
ulm
onar
y m
etas
tase
s; 3
) Lob
ecto
my
14 y
rsN
o fu
rthe
r m
etas
tase
sW
irman
n J.A
. [31
] *38
mal
eR
t. ac
rom
ion
1) R
esec
tion;
2) L
ocal
rec
urre
nce
with
sof
t tis
sue
inva
sion
14yr
s./3
3 yr
s.D
eath
for
norm
al r
easo
ns3)
Rec
urre
nce
and
pulm
onar
y m
etas
tase
s; 4
) Rad
iatio
n th
erap
y
(Rt:
right
; Lt:
Left
; Pro
x: P
roxi
mal
; Dis
t: D
ista
l *W
ellm
ann
[30]
and
Wirm
an [3
1]: T
he o
nly
two
auth
ors
repo
rtin
g of
an
chon
drob
last
oma
of th
e sc
apul
a w
ith m
etas
tase
s) a
nd o
f th
e pa
tient
s’cl
inic
al fe
atur
es.
passive one for 20–0–20. A weight loss of 2kg during8 weeks was registered. Additionally, a new 2x2cmsized soft tissue tumor of the right mandible branch,which was first regarded as atheroma or lesion of thesalvatory gland, was found. CT showed a maximumprimary tumor size of 11 x 5 x 10cm with the main fo-cus at the dorsocranial scapula and massive destruc-tion of the medial scapular third. MRI revealed a pro-gressive and partly neoplastic chondroblastoma with astrong contrast enhancement at the margins (Fig. 2).Another fine needle biopsy proved no alteration ofhistology. Suspecting a malign transformation to achondrosarcoma, an en bloc scapulectomia involvingresection of surrounding soft tissue was performed,The resected specimen had 1255g in weight and22 x 17 x 9cm in size. Histological examination showeda population of monomorphic medium-sized cellswith slightly recessed nuclei, broad and eosinophiliccytoplasm, and sharply defined cell boarders. Theywere presenting mainly giant cells of the osteoclastictype without atypia, but widespread necrosis and con-sistent mitosis (mitotic rate 10/10 HPF). Birefringentcrystal material compatible with calcium pyrophos-phate focally accumulated. Moreover, areas with pro-duction of chondroid matrix and enclosure of differ-entiated chondroid cells were recognized (Fig. 3).Bone destruction, infiltration of adjacent muscles andsubcutaneous soft tissue were found thus establishingthe diagnosis of an aggressive chondroblastoma. Thetumor above the right mandible branch showed slightCT enhancement. Histology revealed the identicalmorphology of the scapular chondroblastoma.
Postoperatively, neither lung metastasis nor any oth-er filia were seen in CT. However, the right mandibletumor showed slight enhancement in 99mTc bonescintigraphy with the histological diagnosis of a metas-tasis of the scapular chondroblastoma. Two and a half
years after the final surgery, the patient still presentedfree of metastases with an acceptable range of motionregarding his left upper limb.
DISCUSSION
The first description of chondroblastoma was given byCodman in 1931, who designated it as “epiphysealchondromatous giant cell tumor” [3]. Jaffe and Licht-enstein differentiated in 1942 the chondroblastomafrom giant cell tumors and established the term “be-nign chondroblastoma” [12]. Chondroblastoma is arare tumor with an incidence of 1% of all benign bonetumors. In up to 95% it occurs in the second decadeof life with a male:female ratio of 2 : 1 [24]. Especiallyin older patients, there were reported a few atypicalcases of chondroblastoma, which tend to involve un-usual sites and have a greater tendency to expand theaffected bone. This observation was confirmed by thepresent case in an 68-year old male. Chondroblastomahas a predilection for the epiphysis of the femur,humerus, tibia and tarsal bones. Only 16% of cases arefound in flat bones [1, 5]. Scapular location of a chon-droblastoma, as described in our case, has been re-ported since 1931 in only eleven cases (Table 1). Here-by, our patient is the oldest reported case of scapularaffection in the entire described 12 cases at all. Mostpatients reported pain and local tenderness associatedwith limitation of motion of the adjacent joints. Apathologic fracture as the primary presentation is ex-ceedingly rare, and local swelling is present in less than10 percent [11].
Histogenesis of chondroblastoma is controversial,but derivation from epiphyseal cartilage cells ratherthan from reticulo-histiocytic cells seems to be most
EUROPEAN JOURNAL OF MEDICAL RESEARCH 3
Fig. 1. Photography of the patient’s back before surgery. Atthe upper margin of the left scapula a tumor mass is notable(indicated by the red arrow). The affected shoulder appears tobe elevated in level compared to the opposite, right shoulder.Underneath the tumor mass, a mark of approximately 5cmlength is visible, most likely due to an ancient surgical proce-dure. A defect with consecutive loss of mass of the deltoidmuscle can be seen on the left compared to the right deltoidarea.
Fig. 2. Radiograph of the left shoulder showing a huge calci-fied tumor mass above the clavicle. The tumor shows a scle-rotic inferior margin and extension into the soft tissue, aswell as into the glenoid fossa
likely [5, 24]. The histological diagnosis of typicalchondroblastoma is usually not difficult due to theircharacteristic appearance with rounded or polygonalchondroblasts, multinucleated giant cells, andeosinophilic chondroid extracellular matrix with focal
(chicken wire) calcification [4]. Nonetheless, it is im-portant to be aware of a wide morphologic spectrumcausing possible diagnostic problems. Therefore, thedifferentiation between chondroblastoma and giantcell tumor can be difficult in case of the former con-
EUROPEAN JOURNAL OF MEDICAL RESEARCH4
Fig. 3. Magnetic Resonance Images (MRI) of the left scapula in the parasagittal plane: On the left side (3a, b), MR-images of theyear 2000 are shown: A huge tumorous mass, in the soft tissue beneath the deltoid muscle is visible. The lesion measures11x7x9 cm in size. On fat-suppressed images (3a), a hyperintense, inhomogeneous signal results whereas after contrast applica-tion (3b) a rich enhancement is shown indicating a necrotic central zone. On the right side (3c, d), MR-images 3 years later aredisplayed: A second tumor nodule is now recognizable, located just dorso-caudal to the primary tumor mass (indicated by thered arrow). This nodule is of homogeneous hyperintense signal on fat-suppressed images (3c) and shows homogeneous contrastenhancement (3d) indicating viability.
a c
b d
taining a large number of giant cells and scanty chon-droid matrix. The epiphyseal location and lytic radi-ographic appearance may add to the confusion, butchondroblastoma usually occur in patients youngerthan 20 years with open epiphyseal plates, often in-volving less than one half of the epiphyseal diameter.The mononuclear cells in chondroblastoma will con-tain irregular, ridged nuclei with longitudinal clefts,while in giant cell tumors the cells resemble histiocyteswith nuclei, similar to those of the giant cells [2]. Fo-cally, a network of calcification (chicken wire) betweenthe tumor cells exist, whereas clumps of calcificationwere observable in some areas [22].
Chondroid plaques are not a feature of giant cell tu-mors. In difficult cases, the demonstration of S100positivity in chondroblasts will be helpful [28]. One ofthe most difficult entities being differentiated from achondroblastoma is the Langerhans' cell histiocytosis,which was considered the primary diagnosis in our pa-tient and consecutively led to inadequate initial treat-ment [7]. Cytologically, chondroblasts exhibit roundedcontours and folded or reniform-shaped nuclei, evencontaining prominent grooves. Furthermore, binucle-ate and multinucleate forms are usually present. Thesecytomorphologic features also characterize the diag-nostic histiocytes of Langerhans' cell histiocytosis,which is not associated with any form of matrix pro-
duction [7]. As shown in the present case, immunohis-tochemical results may even not be conclusive for theexclusion of Langerhans' cell histiocytosis showing un-equivocal expression of CD1a.
In an older group of age, the differential diagnosisof a low graded chondrosarcoma may also be consid-ered. However, concerning cytology the cells in achondrosarcoma are larger, with mild to moderatepleomorphism and present in lacunae. Binucleate andmultinucleate cells are frequent along with the pres-ence of hyaline cartilage [20].
Features supportive for a benign lesion will be theabsence of abnormal mitoses and a low mitotic count.The mitotic count of chondroblastoma does not ex-ceed 5/10 HPF in 81% of tumors. In cases with un-usual histologic features, correlation with radiographicfeatures will usually help with the diagnosis. Radiologi-cally, chondroblastoma are usually presented as well-defined eccentric lesions in epiphyseal location with arim of sclerosis with or without punctuate calcifica-tions occurring in approximately 60%. Occasionally,large bubbly bone expansion with varying amounts ofstippled calcifications and periosteal reaction can beevident on radiographs and a secondary aneurismalbone cyst should be considered [5, 6]. A distinctivefeature of chondroblastoma on MRI scans is a pre-dominant low-to-intermediate signal intensity on T1-
EUROPEAN JOURNAL OF MEDICAL RESEARCH 5
Fig. 4. Histological HE staining: Numerous chondroblastswith eosinophilic cytoplasm and distinct cell borders as wellas mitotic activity are shown. Giant cells of osteoclastic type,varying in size are also visible (4a). S 100 Immunohisto-chemistry: Cytoplasmic staining in the mononuclear cells isshown (4b). CD 68 Immunohistochemistry: The mononu-clear cells remain unstained. The staining is confined to theosteoclastic giant cells (4c).
a c
b
weighted images with heterogeneous intermediate sig-nal on T2-weighted images, with only scattered foci ofhigh signal intensity. This low-to-intermediate signalintensity appears due to cellular chondroid matrix andalso calcification [14].
According to malignant tumor behavior concerningthe spread of metastases, there are a few documentedfatal cases of chondroblastoma showing pulmonarymetastasis of the same histologic characteristics as theremoved tumor, [10, 13, 19] thus presenting a metasta-tic chondroblastoma. Those cases have in commonthat surgical therapy always happened prior to the ap-pearance of metastases. Therefore, metastases mayrepresent a vascular transport phenomenon duringvigorous curettage [13]. Our patient also seems to beone-of-a-kind due to the fact that except fine needlepuncture no tumor manipulation was performed.Chondroblastoma is generally treated by curettagewith or without bone grafting with a curative result inapproximately 90% [19]. Cementation or excision andreconstruction may be required for large lesions. Therecurrence rates for chondroblastoma in previousstudies ranged from 5.7% to 20%; in case of sec-ondary aneurismal bone cyst identification, an evenhigher local recurrence rate was reported [10]. In gen-eral, local recurrence is more likely to occur in flatthan in long bones. In some rare cases, chondroblas-toma grow quite large, like in our case, or tend to recurwith or without soft tissue seeding. These large and/orlocal recurrent lesions have been described as aggres-sive variants of chondroblastoma [10, 21]. One mightthink that in these cases a separate, own tumor entityis concerned whereas the cytopathological specificcharacteristics have yet not been described in literaturedue to its rare occurrence [21]. Also the present reportproves that in case of the chondroblastoma remaininguntreated, it can show distinct size-progression, andthus making an en bloc resection necessary, which mayresult in a loss of joint function and growth distur-bance due to the location in the epi- and metaphysealregion [22, 27].
SUMMARY
In summary, the need for a combined and extendedclinical, radiologic, and histologic approach to the cor-rect diagnosis of chondroblastoma is emphasized. Asshown in the present patient, most of the classic crite-ria such as typical location, age, histology and radio-logical appearance are not met in these cases. The pa-tient might be endangered for an inadequate primarytreatment leading to fatal consequences. Therefore, westrongly suggest multiple biopsies of the tumor to geta distinct histological diagnosis. However, the occur-rence of metastatic and malignant behaviour of chon-droblastoma is extremely rare. It should not be takenas an indication for radical therapy like en bloc resec-tion necessary for every primary appearance of chon-droblastoma.
REFERENCES
1. Brien, Mirra JM, Ippolito V. Chondroblastoma arisingfrom a nonepiphyseal site. Skeletal Radiol. 1995; 24:220-222
2. Brien, Mirra JM, Kerr R. Benign and malignant cartilagetumors of bone and joint: their anatomic and theoreticalbasis with an emphasis on radiology, pathology and clini-cal biology. I. The intramedullary cartilage tumors. Skele-tal Radiol. 1997; 26:325-353
3. Codman EA. Epiphyseal chondromatous giant cell tu-mors of the upper end of the humerus. Surg Gynecol Ob-stet 1931; 52:543-548
4. Coleman. Benign chondroblastoma with recurrent soft-tissue and intra-articular lesions. J Bone Joint Surg Am1966; 48:1554-1560
5. Dahlin, Ivins JC. Benign chondroblastoma. A study of125 cases. Cancer 1972; 30:401-413
6. de Silva, Reid R. Chondroblastoma: varied histologic ap-pearance, potential diagnostic pitfalls, and clinicopatho-logic features associated with local recurrence. Ann.Di-agn.Pathol. 2003; 7:205-213
7. Elsheikh, Silverman JF, Wakely PE, Jr., Holbrook CT,Joshi VV. Fine-needle aspiration cytology of Langerhans'cell histiocytosis (eosinophilic granuloma) of bone in chil-dren. Diagn.Cytopathol. 1991; 7:261-266
8. Gawlik, Witwicki T. [Chondroblastoma malignum pri-marium]. Patol.Pol. 1965; 16:181-189
9. Green, Whittaker RP. Benign chondroblastoma. Case re-port with pulmonary metastasis. J Bone Joint Surg Am.1975; 57:418-420
10. Huvos, Higinbotham NL, Marcove RC, O'Leary P. Ag-gressive chondroblastoma. Review of the literature on ag-gressive behavior and metastases with a report of onenew case. Clin.Orthop. 1977;266-272
11. Huvos, Marcove RC. Chondroblastoma of bone. A criti-cal review. Clin.Orthop. 1973; 95:300-312
12. Jaffe HL, Lichtenstein L. Benign chondroblastoma ofbone. A reinterpretation of the so-called calcifying ofchondromatous giant cell tumor. Am J Path 1942; 18:969-983
13. Jambhekar, Desai PB, Chitale DA, Patil P, Arya S. Benignmetastasizing chondroblastoma: a case report. Cancer1998; 82:675-678
14. Jee, Park YK, McCauley TR, Choi KH, Ryu KN, Suh JS,Suh KJ, Cho JH, Lee JH, Park JM, Lee YS, Ok IY, KimJM. Chondroblastoma: MR characteristics with patholog-ic correlation. J Comput.Assist.Tomogr. 1999; 23:721-726
15. Joshi, Anderson PM, Matsumoto J, Moir C, Shives T,Unni K, Lennon VA. Metastatic chondroblastoma withelevated creatine kinase and paraneoplastic neurologic au-toimmunity. J Pediatr.Hematol.Oncol. 2003; 25:900-904
16. Kahn, Wood FM, Ackerman LV. Malignant chondroblas-toma. Report of two cases and reviw of the literature.Arch.Pathol. 1969; 88:371-376
17. Khalili, White LM, Kandel RA, Wunder JS. Chondroblas-toma with multiple distant soft tissue metastases. SkeletalRadiol. 1997; 26:493-496
18. Kunze, Graewe T, Peitsch E. Histology and biology ofmetastatic chondroblastoma. Report of a case with a re-view of the literature. Pathol.Res.Pract. 1987; 182:113-123
19. Kyriakos, Land VJ, Penning HL, Parker SG. Metastaticchondroblastoma. Report of a fatal case with a review ofthe literature on atypical, aggressive, and malignant chon-droblastoma. Cancer 1985; 55:1770-1789
20. Levine, Bensch KG. Chondroblastoma--the nature of thebasic cell. A study by means of histochemistry, tissue cul-ture, electron microscopy, and autoradiography. Cancer1972; 29:1546-1562
21. Mirra, Ulich TR, Eckardt JJ, Bhuta S. "Aggressive" chon-droblastoma. Light and ultramicroscopic findings after enbloc resection. Clin.Orthop. 1983;276-284
22. Ramappa, Lee FY, Tang P, Carlson JR, Gebhardt MC,Mankin HJ. Chondroblastoma of bone. J Bone Joint SurgAm. 2000; 82-A:1140-1145
EUROPEAN JOURNAL OF MEDICAL RESEARCH6
23. Riddell, Louis CJ, Bromberger NA. Pulmonary metas-tases from chondroblastoma of the tibia. Report of acase. J Bone Joint Surg Br. 1973; 55:848-853
24. Schajowicz, Gallardo H. Epiphysial chondroblastoma ofbone. A clinico-pathological study of sixty-nine cases. JBone Joint Surg Br. 1970; 52:205-226
25. Sirsat, Doctor VM. Benign chondroblastoma of bone.Report of a case of malignant transformation. J BoneJoint Surg Br. 1970; 52:741-745
26. Sweetnam, Ross K. Surgical treatment of pulmonarymetastases from primary tumours of bone. J Bone JointSurg Br. 1967; 49:74-79
27. Turcotte, Kurt AM, Sim FH, Unni KK, McLeod RA.Chondroblastoma. Hum.Pathol. 1993; 24:944-949
28. Ushigome, Takakuwa T, Shinagawa T, Takagi M, Kishi-moto H, Mori N. Ultrastructure of cartilaginous tumorsand S-100 protein in the tumors. With reference to thehistogenesis of chondroblastoma, chondromyxoid fibro-ma and mesenchymal chondrosarcoma. Acta Pathol.Jpn.1984; 34:1285-1300
29. van Horn, Vincent JG, Wiersma-van Tilburg AM,Pruszczynski M, Slooff TJ, Molkenboer JF. Late pul-monary metastases from chondroblastoma of the distalfemur. A case report. Acta Orthop.Scand. 1990; 61:466-468
30. Wellmann. Chondroblastoma of the scapula. A case re-port with ultrastructural observations. Cancer 1969; 24:408-416
31. Wirman, Crissman JD, Aron BF. Metastatic chondroblas-toma: report of an unusual case treated with radiotherapy.Cancer 1979; 44:87-93
Received: December 7, 2005 / Accepted: February 6, 2006
Address for correspondence:Dr.med. Chlodwig KirchhoffOrthopädische Klinik und PoliklinikKlinikum GrosshadernLudwig-Maximilians Universität MünchenMarchioninistrasse 15D-81366 Munich, GermanyE-mail: [email protected]
Senior Author:Prof. Dr. med. Hans-Roland DürrOrthopädische Klinik und PoliklinikKlinikum GrosshadernLudwig-Maximilians Universität MünchenMarchioninistrasse 15D-81366 MunichE-Mail: [email protected]
EUROPEAN JOURNAL OF MEDICAL RESEARCH 7